CAS 1312299-39-0

Concizumab

CAS: 1312299-39-0

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, thereby blocking the

Reinheit: > 95%

Farbe und Form: Liquid

Molekulargewicht: 145.76 kDa

Ref: TM-T77373

Concizumab

CAS: 1312299-39-0

A neutralizing human monoclonal antibody that blocks Macrophage-stimulating 1-receptor (RON) binding to macrophage-stimulating protein (MSP).

Ref: 3D-CLA1315